论著

超声造影评价不同厚度颈动脉斑块内新生血管的临床研究

Evaluation of neovascularization in carotid arteries with different thickness by contrast enhanced ultrasound

:46-49
 
目的 通过超声造影成像技术( CEUS)观察颈动脉斑块内新生血管的情况,探讨颈动脉斑块的厚度与新生血管的关系。方法 选择颈动脉粥样硬化患者40例,经常规超声确诊存在斑块,共64个,应用CEUS成像技术检测斑块内新生血管情况。结果 不同厚度的颈动脉斑块的增强强度与斑块厚度成正相关(r=0.897 6,P=0.000 0)。结论 超声造影成像技术可以在常规超声的基础上通过检测斑块内的新生血管,进而判断斑块的性质,提供更多有用的信息进一步评估颈动脉斑块内新生血管增强强度与斑块厚度存在线性正相关性。
Objective To evaluate the neovascularization in carotid plaques by gray-scale harmonic contrast echocardiography (CEUS), and to investigate the relationship between the thickness of carotid artery plaque and the neovascularization.Methods 40 patients with carotid atherosclerosis were selected, and 64 plaques were diagnosed by regular ultrasound. The neovascularization in plaques was detected by CEUS imaging technique.Results The enhanced strength of carotid plaques with different thickness was positively correlated with plaque thickness (r=0.8976,P=0.0000).Conclusion Ultrasound contrast imaging can detect angiogenesis within the plaque based on conventional ultrasound, and then determine the nature of the plaque. More useful information is provided to further evaluate the linear positive correlation between the intensity of neovascularization and the thickness of plaque in carotid plaque.
论著

结肠黑变病对结肠息肉的影响

The effects of melanosis coli on colon polyps

:19-22
 
目的 研究结肠黑变病(melanosis coli,MC)对结肠息肉的影响。方法 从2014年1月—2017年1月在石河子大学医学院第一附属医院行电子结肠镜的21 708例患者中选取符合条件的522例结肠黑变病患者组成MC组,随机选取569例患者组成非MC组,分析比较2组的一般情况及与结肠息肉的关系,非正态分布的计量资料以中位数表示,采用秩和检验,两组计数资料采用χ2检验。结果 结肠黑变病组年龄中位数为64岁(51~73岁),非结肠黑变病组年龄中位数为54岁(47~64岁),2组性别无统计学差异;MC组、非MC组结肠息肉检出率分别为47.8%和40.2%,P=0.013,差异有统计学意义;在病理类型上2组均为炎性息肉检出率最低,腺瘤性息肉检出率最高分别达 58.0%和51.5%,病理类型无统计学差异;在盲肠及降结肠检出率均很低,多发部位、直肠、乙状结肠检出率相对较高,但差异均无统计学意义;结肠息肉大小集中在0~9 mm范围内,2组所占百分比分别高达92.0%和91.3%,≥20 mm息肉检出率均很低,分别为0.40%,0.44%,息肉大小无统计学差异。结论 MC组息肉检出率高于非MC组,差异有统计学意义;2组结肠息肉病理类型、发病部位、息肉大小差异均无统计学意义。
Objective Studying the effect of melanosis coli (MC) on colonic polyps.Methods This is a reospectively review of patients with electronic colonoscopy in our hospital from January 2014 to January 2017. A total of 522 cases of colorectal melanosis (MC) were composed of MC group, and 569 patients were randomly selected to form a non-mc group. The comparison of basic information between the two groups and the relationship of colon polyp and colon cancer was analyzed.Results The median age of the colon melanosis group was 64 years (51~73 years old), and the median age of the non-colonic melanosis group was 54 years (47 to 64 years old), with no statistically significant differences between the two groups.The detection rate of colon polyps in MC group was 47.8%. The detection rate of colon polyps in non-mc group was 40.2%, P= 0.013, and the difference was statistically significant.The two groups of polyps had the lowest detection rate of inflammatory polyps in pathological types, and the detection rate of adenomatous polyps was up to 58.0% and 51.5% respectively, but there was no statistically significant difference between the two groups. In the cecum, the detection rate of the descending colon was low, and the detection rate of multiple sites, rectum and sigmoid colon was relatively high, but the difference was not statistically significant.The size of colon polyps was concentrated in the range of 0~9 mm, and the percentages of the two groups were as high as 92.0% and 91.3% respectively, while the detection rate of the size being more than 20mm was low, that is 0.40% and 0.44%. But there was no statistical difference between the two groups.Conclusion The detection rate of polyps in MC group was higher than that in non-mc group, and the difference was statistically significant.There was no statistically significant difference between the two groups of colon polyps pathology, pathogenesis, and polyp size.
论著

前列地尔联合依帕司他对糖尿病足患者创面肉芽组织TNF-α、IL-6、VEGF表达影响

Effects of combination of alprostadil and epalatone on expression of TNF-α, IL-6 and VEGF in granulation tissue of patients with diabetic foot

:10-14
 
目的 探讨前列地尔联合依帕司他对糖尿病足患者创面肉芽组织肿瘤坏死因子(tumor necrosis factor-α,TNF-α)、白介素-6 (interleukin-6,IL-6)及血管内皮生长因子(vascular endothelial growth factor,VEGF)表达的影响。方法 将90例糖尿病足患者随机分为研究组和对照组,每组45例,对照组予常规治疗,研究组在常规治疗基础上给予前列地尔+依帕司他联合治疗。监测两组患者创面愈合率,患肢足背血流动力学及腓总神经传导速度,创面肉芽组织TNF-α、IL-6、VEGF含量及基因表达变化。结果 治疗后第2、4周研究组较对照组创面愈合率升高,差异有统计学意义(P<0.05);治疗后两组患者足背动脉血流动力学及腓总神经传导速度均有改善,而研究组疗效更明显(P<0.05);治疗后研究组患者创面肉芽组织TNF-α、IL-6含量及基因表达较对照组降低,VEGF含量及基因表达则升高(P<0.05)。结论 前列地尔联合依帕司他联合治疗可改善糖尿病足患者足背动脉血流动力学,促进受损神经功能恢复;降低糖尿病足患者创面肉芽组织TNF-α、IL-6表达,减轻免疫损伤;增加VEGF基因表达,促进血管生成,加速创伤愈合。
Objective To investigate the effects of alprostadil combined with epalrestat on the expression of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF) in granulation tissue in patients with diabetic foot patients.Methods Totally 90 cases with diabetic foot were randomly divided into study group (45 cases)and control group(45 cases). The control group received conventional treatment for 4 weeks and the study group additionally received combination of alprostadil and epalatone for 4 weeks. The curative rate of wound healing, limb dorsal hemodynamics, peroneal nerve conduction velocity and the levels of TNF-α, IL-6 and VEGF in the granulation tissue of the wound were monitored in the two groups.Results The wound healing rate of the study group was significantly higher than that of the control group at the 2nd and 4th week after treatment (P<0.05). After treatment, the hemodynamics and peroneal nerve conduction velocity were improved (P<0.05). The contents and expressions of TNF-α and IL-6 in the granulation tissue of the treatment group were significantly lower than that of the control group, and the content of VEGF and gene expression were significantly increased in the study group (P<0.05).Conclusion The combination therapy of alprostadil and epalrestat may improve the hemodynamics of dorsalis pedis artery in patients with diabetic foot and promote the recovery of damaged nerve function.Also it may reduce the expression of TNF-α and IL-6 in the granulation tissue of diabetic patients and reduce the immune injury. It promotes angiogenesis and accelerates wound healing by increasing VEGF gene expression.
临床诊疗

不同分化程度前列腺癌经直肠超声图像特征观察

Image features of differentiated degree prostate pre rectum ultrasound

:103-105
 
目的 探讨不同分化程度前列腺癌患者的直肠超声图像特征,为前列腺癌分化程度的诊断提供依据。方法 纳入我院收治的前列腺癌患者120例,均接受直肠超声检查,根据Gleason评分评估分化程度分成低分化组(n=41)、中分化组(n=39)与高分化组(n=40)。分析不同分化程度患者的结节大小、血流分级、回声、边界是否清晰以及包膜完整性,并对血流频谱进行观察。结果 低分化组的结节≥10 mm、肿瘤组织周围血流分布Ⅱ~Ⅲ级、边界欠清晰、包膜欠完整、高回声占比高于高分化组,且低分化组结节≥10 mm、肿瘤组织周围血流分布Ⅱ~Ⅲ级、高回声占比高于中分化组,中分化组结节≥10 mm、肿瘤组织周围血流分布Ⅱ~Ⅲ级、高回声占比高于低分化组,差异有统计学意义(P<0.05)。结论 不同分化程度前列腺癌患者的直肠超声表现存在差异,随着分化程度越低,肿瘤边界清晰度、包膜完整性越差,血流越丰富。
临床诊疗

复合声及心理辅导联合利多卡因与甲强龙综合治疗特发性耳鸣的临床疗效

Clinical efficacy of combined sound and psychological counseling combined with lidocaine and methylprednisolone in the treatment of idiopathic tinnitus

:97-99
 
目的 探讨复合声及心理辅导联合耳后注射利多卡因与甲强龙综合治疗特发性耳鸣的临床疗效。方法 选择符合纳入标准的耳鸣患者60例,随机分为耳后注射利多卡因与甲强龙组(A组)20例、心理辅导联合复合声组(B组)20例、耳后注射利多卡因与甲强龙联合心理辅导及复合声组(C组)20例,分别于治疗后1月、3月,通过耳鸣严重程度评估指标及评分标准评估三种治疗方式的疗效。结果 3组患者治疗3个月后A组总有效率为50 %, B组45%, C组90%,且组间有差异(P<0.05)。另外,除A组与B组之间无差异外,C组与A组(P=0.0058)、B组(P=0.0024)之间均有差异。结论 实验结果表明复合声及心理辅导联合利多卡因与甲强龙综合治疗特发性耳鸣能有效治疗耳鸣,提高患者生存质量,在耳鸣临床治疗中明显具有积极作用,临床应用前景广阔。
临床诊疗

99锝-亚甲基二膦酸盐治疗前列腺癌骨转移疗效观察

Observation of curative effect of prostate cancer osseous metastasis treated by technetium [99mtc] methylenediphosphonate injection

:94-96
 
目的 观察99锝-亚甲基二膦酸盐对前列腺癌骨转移患者骨痛、骨质疏松的治疗效果。方法 对76例前列腺癌骨转移患者给予99锝-亚甲基二膦酸盐治疗1年(每疗程15 d,每天静滴22 mg,15 d为一个疗程,共12个疗程),比较治疗前及治疗1年后患者骨密度(BMD)值及血清钙、磷、碱性磷酸酶、骨钙素、I型胶原交联羧基末端肽、1,25二羟维生素D3等指标的变化。结果 云克治疗后腰椎(L1-4)及左股骨颈、大转子及小转子骨密度(BMD)值均较治疗前增加(P<0.05);云克治疗后AKP、ICTP均较治疗前明显下降(P<0.01)。OC云克治疗后较治疗前增加(P<0.05)。血钙、血磷、1,25-二羟维生素D3云克治疗后与云克治疗前相比无明显变化,P<0.05。前列腺癌骨转移轻度骨痛组及中度骨痛组治疗1年后骨痛VAS评分明显降低,差异有统计学意义,P<0.05。重度骨痛组云克治疗前、治疗后VAS评分比较,差异无统计学意义,P<0.05。结论 99锝-亚甲基二膦酸盐在治疗前列腺癌骨转移的骨痛、骨质疏松方面,具有缓解骨痛,促进骨增殖,抑制骨吸收,提高骨密度,防治骨质疏松的作用。
临床诊疗

丹参酮ⅡA磺酸钠不同时点给药在高血压性脑出血治疗中的疗效及对神经保护作用

Clinical efficacy and neuroprotective effect of Tanshinone ⅡA sodium sulfonate in the treatment of hypertensive intracerebral hemorrhage

:91-93
 
目的 探讨高血压性脑出血在不同时点给药丹参酮ⅡA磺酸钠的疗效分析及对神经保护作用。方法 选取我院2014年10月—2016年10月期间收治的66例高血压性脑出血患者作为研究对象,按照随机数字表的方法分为观察组(n=33)和对照组(n=33),对照组患者于入院后第10天采用丹参酮ⅡA磺酸钠进行治疗,观察组则于入院后第3天采用丹参酮ⅡA磺酸钠进行治疗,分别对2组患者的临床疗效、不良反应、治疗前后的神经功能以及随访一年的脑卒中影响量表(SIS)进行客观比较。结果 经比较,观察组患者的临床总有效率为90.90%,对照组的临床总有效率为69.70%,2组比较,差异有统计学意义(P<0.05);观察组患者的不良反应稍低于对照组,但2组比较差异无统计学意义(P>0.05);此外,观察组患者治疗后的神经功能评分优于对照组和治疗前,差异有统计学意义(P<0.05);在随访一年的时间里发现,观察组患者的SIS量表亦更优于对照组(P<0.05)。结论 早期采用药丹参酮ⅡA磺酸钠治疗高血压性脑出血的临床疗效显著,不良反应相对较小,且在一定程度上发挥了保护患者神经功能的作用,值得推广。
Objective: To investigate the effect of tanshinone II A sulfonate treatment on hypertensive cerebral hemorrhage at different time and the neuroprotective effect. Methods: In our hospital from October 2014 to October 2016 66 cases of hypertensive cerebral hemorrhage patients were enrolled as the research object, according to the random number table method divided into observation group (n=33) and control group (n=33), patients in the control group on the tenth day after admission of sodium tanshinone A sulfonate treatment, The observation group was treated with tanshinone A sodium sulfonate on the third day after admission. The clinical efficacy, adverse reactions, neurological function before and after treatment, and Stroke Scale (SIS) were compared between the two groups. Results: by comparison, the observation group of patients with clinical total efficiency 90.90%, clinical control group in the total efficiency 69.70%, compared with significant difference (P<0.05); to observe the adverse reaction of patients was slightly lower than that of control group, but the difference between the two groups was not statistically significant (P>0.05); in addition, the patients in the observation group the neurological score was significantly better than the control group and before treatment, the difference was significant (P<0.05); Conclusion: the early treatment of sodium tanshinone II A sulfonate in the treatment of hypertensive intracerebral hemorrhage has a significant clinical effect, a relatively small adverse reaction, and to a certain extent, it plays a protective role in patients with neurological function, and is worthy of promotion.
临床诊疗

血必净联合乌司他丁治疗重症急性胰腺炎的疗效及对血清细胞因子水平的影响

Curative effect of Xuebingjing combined with ulinastatin injection on severe acute pancreatitis and its influence of serum cytokines

:71-72
 
目的 探究血必净联合乌司他丁治疗重症急性胰腺炎的疗效及对血清细胞因子水平的影响。方法 选择2016年2月—2017年3月我院收治的重症急性胰腺炎患者88例,随机将其为两组,各44例。对照组采用乌司他丁治疗,在此基础上给予观察组血必净治疗,比较2组临床疗效、血清细胞因子及药物不良反应。结果 观察组总有效率较对照组高,TNF-α、IL-6、hs-CRP水平较对照组低,差异有统计学意义(P<0.05);观察组不良反应率略低于对照组,但差异无统计学意义(P>0.05)。结论 血必净联合乌司他丁可提高重症急性胰腺炎临床疗效,减轻炎性反应,且不增加不良反应率,安全性较高。
论著

CD117在肺基底样细胞鳞状细胞癌与小细胞肺癌中的鉴别诊断作用

The role of CD117 in differentiating basaloid squamous cell carcinoma from small cell carcinoma in lung

:44-47
 
目的 探讨CD117在肺基底样细胞鳞状细胞癌(BSCC)与小细胞肺癌(SCLC)中的鉴别诊断作用。方法 免疫组织化学检测CD117在肺BSCC与SCLC中的表达情况,并进行统计学分析,同时文献复习CD117在这两种肿瘤中的表达情况。结果 CD117在SCLC中特异性高表达(阳性率为78%),并且具有高的敏感度、特异度、阳性预测值及阴性预测值(分别为100%、78.2%、68.7%、100%),与文献报道一致(阳性率37%~100%);而在BSCC中未见有CD117的表达,文献未见有CD117在BSCC中表达情况报道。结论 CD117有可能成为鉴别诊断BSCC与SCLC的重要指标之一。但由于本报道例数有限,还需要更大型的研究进一步证明CD117在鉴别诊断二者中的敏感度及特异度。
Objective To investigate the role of CD117 in differentiating basaloid squamous cell carcinoma (BSCC) from small cell carcinoma (SCLC) in lung. Methods Immunohistochemistry staining of CD117 and statistic data were analyzed in BSCC and SCLC, and relevant literature were reviewed. Results CD117 was specifically expressed in high level ( positive rate 78%) in SCLC with high sensitivity, specificity, positive predictive value and negative predictive value (respectively 100%、78.2%、68.7%、100%), which was highly consistent with literature reports (positive rate 37%-100%). CD117 was not detected in BSCC in our report and it was the same as in literatures. Conclusion Although our results showed that it was possible that the expression of CD117 would play an important role in differentiating BSCC from SCLC, due to limited cases in number, more studies are needed to elucidated the sensitivity and specificity.
论著

不同剂量阿托品对右美托咪定心脏窦房结及房室结抑制作用的逆转效果

Reversal effect of atropine on the function of sinus node and the atrioventricular node inhibiting action by dexmedetomidine

:33-36
 
目的 观察两种不同剂量的阿托品对右美托咪定心脏窦房结及房室结抑制作用的逆转效果。方法 健康志愿者20名,男12名,女8名,18~30岁。受试者先后给予右美托咪啶(1.5±0.5)μg/kg负荷量,持续泵注量(0.75±0.25)μg/(kg·h)进行试验观察。试验过程中如受试者心率<(50±5)次/分,房室结前传2∶1小于150次/分的受试者随机进入0.5 mg阿托品剂量拮抗组(A1),1 mg阿托品剂量拮抗组(A1),每组10例。与泵注前(T0),静脉泵注右美托咪定后(50±5)min(T1),阿托品静脉推注后(10±5)min(T2)经食道左心房调搏测定窦房结恢复时间(SNRT),校正窦房结恢复时间(CSNRT),房室结前传2∶1点阻滞点和房室结有效不应期(AVNERP)测量。结果 组内比较:泵注右美托咪定后T1时点与基础值T0时点比较两组窦房结及房室结功能受到抑制,SNRT 均延长(P<0.05),CSNRT比较无差异(P>0.05),房室结前传2∶1阻滞点降低(P<0.05), AVNERP延长(P<0.05)。阿托品使用后T2时点的A1组的各指标及A2组的AVNERP恢复到基础水平(P>0.05),A2组的SNRT、CSNRT均较T0时点缩短(P<0.05),A2组房室结前传2∶1阻滞点均较T0时点增高(P<0.05)。组间比较:2组T0时窦房结及房室结功能各指标比较均无差异(P>0.05),T2时点A2组SNRT、AVNERP较A1缩短(P<0.01),T2时点A2组2∶1阻滞点均较A1组增高(P<0.05)。结论 0.5 mg阿托品能逆转右美托咪定心脏窦房结及房室结抑制作用,1 mg阿托品增进右美托咪定影响下的窦房结及房室结传导功能。
Objective To investigate two different doses atropine make reverse effects on the function of sinus node and the atrioventricular node inhibiting action dexmedetomidine (Dex). Methods 20 healthy volunteers were included in the clinical trials aged 18~30 years (12 male, 8 female). The volunteers were administered with Dex at loading dose 1.5±0.5 μg/kg and then at 0.75±0.25 μg/(kg·h). During the trail, the volunteers who happened the minimal heart rate less than 50±5 bpm, atrioventricular node forward 2∶1 block point less than 150 bpm needed to randomly accept 0.5 mg(group A1)or 1 mg(group A2)atropine to antagonize(n=10). SNRT, CSNRT, AVN 2∶1 block point and AVNERP were recorded through TELAP. Results Intra-group comparison indicated functional parameters of SN and AVN were inhibited by Dexsat T1. SNRT were prolonged (P<0.05), AVN 2∶1 block point were decreased (P<0.05),AVNERP were prolonged at T1 compared with T0(P<0.05). All indexes in group A1 and AVNERP in group A2 were back to basal level after using atropine at T2(P<0.05). SNRT, CSNRT were shorted at T2 compared with T0 in group A2(P<0.05). AVN 2∶1 block point had more increased at T2 compared with T0 in group A2(P<0.05). Inter-group comparison indicated no significant differences in functional parameters of SN、AVN at T0(P>0.05). SNRT, AVNERP were shorted at T2 in group A2 compared with group A1. AVN 2∶1 block point were increased at T2 in group A2 compared with group A1. Conclusion 0.5 mg atropine may reverse the function of SN and AVN that are inhibited by Dex. 1 mg atropine may increase functions of SN and AVN that are inhibited by Dex.
出版者信息








《广州医药》公众号